Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures
ClinicalTrials.gov study NCT00404924. IPD Sharing: Not stated. Countries: 22. Publications: 1.
Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review
ClinicalTrials.gov study NCT04609319. IPD Sharing: NO. Countries: 3. Publications: 1.
Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M
ClinicalTrials.gov study NCT02841579. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations
ClinicalTrials.gov study NCT02588261. IPD Sharing: YES. Countries: 23. Publications: 1.
A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)
ClinicalTrials.gov study NCT02411448. IPD Sharing: YES. Countries: 14. Publications: 13.
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02438722. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)
ClinicalTrials.gov study NCT02503735. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation
ClinicalTrials.gov study NCT01953913. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery
ClinicalTrials.gov study NCT03433469. IPD Sharing: NO. Countries: 1. Publications: 1.
LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations
ClinicalTrials.gov study NCT00525148. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positiv
ClinicalTrials.gov study NCT04795245. IPD Sharing: NO. Countries: 1. Publications: 1.
BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)
ClinicalTrials.gov study NCT01562028. IPD Sharing: Not stated. Countries: 8. Publications: 4.
Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)
ClinicalTrials.gov study NCT02856893. IPD Sharing: Not stated. Countries: 6. Publications: 1.
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
ClinicalTrials.gov study NCT04129502. IPD Sharing: YES. Countries: 24. Publications: 1.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of the Oral Anaplastic Lymphoma Kinase (ALK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Brigat
ClinicalTrials.gov study NCT01449461. IPD Sharing: YES. Countries: 0. Publications: 3.
Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02879994. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
ClinicalTrials.gov study NCT00140556. IPD Sharing: Not stated. Countries: 1. Publications: 8.
A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
ClinicalTrials.gov study NCT02573324. IPD Sharing: YES. Countries: 28. Publications: 3.
Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression F
ClinicalTrials.gov study NCT00993499. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)
ClinicalTrials.gov study NCT03974022. IPD Sharing: NO. Countries: 13. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.